Ceftazidime NXL104
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ceftazidime NXL104, covering 2017-09-01 to 2017-09-01. Get the full timeline:
Most recent: Clinical Trial Update: A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers [Phase 1]